ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

  • P-ISSN2233-4203
  • E-ISSN2093-8950
  • ESCI, SCOPUS, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Estimation and Analysis Methods for Trastuzumab Deamidation Levels Using Mass Spectrometry

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2024, v.15 no.2, pp.107-119
https://doi.org/10.5478/10.5478/MSL.2024.15.2.107
Daebong Moon (Binex Co., Ltd.)
Geonwoo Kim (Binex Co., Ltd.)
Minjae Park (Binex Co., Ltd.)
Sunyeol Hong (Binex Co., Ltd.)
Mihyeon Nam (Binex Co., Ltd.)
Sungsic Park (Chungbuk National University)
Jintae Hong (Chungbuk National University)
  • 다운로드 수
  • 조회수

Abstract

We aimed to develop a suitable quantification method for detecting asparagine deamidation and aspartic acid isomer- ization in peptide mapping using LC-MS. Our assessment of its validity and suitability involved comparing its quantitative find- ings with those obtained from cation-exchange chromatography and capillary electrophoresis methods. By subjecting trastuzumab to rigorous conditions to induce these modifications, we validated the efficacy of this new analytical method in pep- tide mapping via LC-MS, evaluating both qualitative and quantitative aspects of asparagine deamidation and aspartic acid isom- erization. Our investigation underscored the significance of enzyme selection and the presence of miss-cleaved or non-specific peptides in achieving accurate quantitative results. The experimental results demonstrated a strong correlation with results from cation-exchange chromatography and capillary electrophoresis analyses, confirming the reliability of the LC-MS based peptide mapping approach.

keywords
mass spectrometry, quantification method, asparagine deamidation, Trastuzumab, aspartic acid isomerization, pep- tide mapping, tandem mass, CID, ETD


투고일Submission Date
2024-05-23
수정일Revised Date
2024-06-20
게재확정일Accepted Date
2024-06-20
상단으로 이동

Mass Spectrometry Letters